Explore more publications!
Business Update France
Got News to Share?

Business Update France: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Update France.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on January 29, 2026

Newsmatics Launches PRSSA Student-Firm Influencer Campaign Highlighting the Role of Press Releases in Modern PR
Jan. 29, 2026

Newsmatics Launches PRSSA Student-Firm Influencer Campaign Highlighting the Role of Press Releases in Modern PR

Indeterminate EIN Presswire
MontaVista Launches MVShield support for Rocky Linux 10 and Alma Linux 9 and 10
Jan. 29, 2026

MontaVista Launches MVShield support for Rocky Linux 10 and Alma Linux 9 and 10

Indeterminate EIN Presswire
Tomorrow University Launches Six Impact MBA Programs for Human-Centric Leadership in the Age of AI
Jan. 29, 2026

Tomorrow University Launches Six Impact MBA Programs for Human-Centric Leadership in the Age of AI

Indeterminate EIN Presswire
AB Science receives notice of allowance for US patent covering masitinib in the treatment of metastatic castrate resistant prostate cancer
Jan. 29, 2026

AB Science receives notice of allowance for US patent covering masitinib in the treatment of metastatic castrate resistant prostate cancer

Indeterminate GlobeNewswire
AB Science reçoit un avis d'autorisation pour un brevet américain couvrant le masitinib dans le traitement du cancer de la prostate métastatique hormono-resistant
Jan. 29, 2026

AB Science reçoit un avis d'autorisation pour un brevet américain couvrant le masitinib dans le traitement du cancer de la prostate métastatique hormono-resistant

Indeterminate GlobeNewswire
Stellantis to Present Strategic Plan at May 21 Investor Day
Jan. 29, 2026

Stellantis to Present Strategic Plan at May 21 Investor Day

Indeterminate GlobeNewswire
Statement re Acciaierie d'Italia
Jan. 29, 2026

Statement re Acciaierie d'Italia

Indeterminate GlobeNewswire
Virtune notiert Virtune Sui ETP an der Deutschen Börse Xetra in Deutschland
Jan. 29, 2026

Virtune notiert Virtune Sui ETP an der Deutschen Börse Xetra in Deutschland

Indeterminate GlobeNewswire
Virtune lists Virtune Sui ETP on Deutsche Börse Xetra in Germany
Jan. 29, 2026

Virtune lists Virtune Sui ETP on Deutsche Börse Xetra in Germany

Indeterminate GlobeNewswire
Virtune lanserar Virtune Sui ETP på Deutsche Börse Xetra i Tyskland
Jan. 29, 2026

Virtune lanserar Virtune Sui ETP på Deutsche Börse Xetra i Tyskland

Indeterminate GlobeNewswire
Press release: 2025: strong sales and EPS growth. Continued profitable growth expected in 2026
Jan. 29, 2026

Press release: 2025: strong sales and EPS growth. Continued profitable growth expected in 2026

Indeterminate GlobeNewswire
Communiqué de presse : 2025 : année de forte croissance du chiffre d’affaires et du BNPA. Poursuite d’une croissance rentable attendue en 2026
Jan. 29, 2026

Communiqué de presse : 2025 : année de forte croissance du chiffre d’affaires et du BNPA. Poursuite d’une croissance rentable attendue en 2026

Indeterminate GlobeNewswire
Nokia provides recast comparative segment results for 2025 and 2024 reflecting new operating and financial reporting structure
Jan. 29, 2026

Nokia provides recast comparative segment results for 2025 and 2024 reflecting new operating and financial reporting structure

Indeterminate GlobeNewswire
Nokia julkistaa uudelleenluokitellut uutta toimintamallia ja taloudellista raportointirakennetta vastaavat segmenttikohtaiset taloudelliset tiedot vuosilta 2025 ja 2024
Jan. 29, 2026

Nokia julkistaa uudelleenluokitellut uutta toimintamallia ja taloudellista raportointirakennetta vastaavat segmenttikohtaiset taloudelliset tiedot vuosilta 2025 ja 2024

Indeterminate GlobeNewswire
OSE Immunotherapeutics Selects Chronic Pouchitis and Hidradenitis Suppurativa as New Key Indications for Lusvertikimab
Jan. 29, 2026

OSE Immunotherapeutics Selects Chronic Pouchitis and Hidradenitis Suppurativa as New Key Indications for Lusvertikimab

Indeterminate GlobeNewswire
OSE Immunotherapeutics sélectionne la pouchite chronique et l’hidradénite suppurée comme nouvelles indications clés pour Lusvertikimab
Jan. 29, 2026

OSE Immunotherapeutics sélectionne la pouchite chronique et l’hidradénite suppurée comme nouvelles indications clés pour Lusvertikimab

Indeterminate GlobeNewswire
Hallituksen ehdotukset Nokia Oyj:n vuoden 2026 varsinaiselle yhtiökokoukselle
Jan. 29, 2026

Hallituksen ehdotukset Nokia Oyj:n vuoden 2026 varsinaiselle yhtiökokoukselle

Indeterminate GlobeNewswire
Proposals by the Board of Directors to Nokia Corporation’s Annual General Meeting 2026
Jan. 29, 2026

Proposals by the Board of Directors to Nokia Corporation’s Annual General Meeting 2026

Indeterminate GlobeNewswire
Ipsen nominates Peter Guenter to its Board of Directors
Jan. 29, 2026

Ipsen nominates Peter Guenter to its Board of Directors

Indeterminate GlobeNewswire
Ipsen nomme Peter Guenter au sein de son Conseil d’Administration
Jan. 29, 2026

Ipsen nomme Peter Guenter au sein de son Conseil d’Administration

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions